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The bacterium Rickettsia rickettsii is the etiological agent of an acute, severe disease called Rocky Mountain 
spotted fever in the United States or Brazilian spotted fever (BSF) in Brazil. In addition to these two countries, the 
disease has also been reported to affect humans in Mexico, Costa Rica, Panama, Colombia and Argentina. Like 
humans, dogs are also susceptible to R. rickettsii infection. However, despite the wide distribution of R. rickettsii in 
the Western Hemisphere, reports of R. rickettsii-induced illness in dogs has been restricted to the United States. The 
present study evaluated the pathogenicity for dogs of a South American strain of R. rickettsii. Three groups of dogs 
were evaluated: group 1 (G1) was inoculated ip with R. rickettsii; group 2 (G2) was infested by R. rickettsii-infected 
ticks; and the control group (G3) was infested by uninfected ticks. During the study, no clinical abnormalities, 
Rickettsia DNA or R. rickettsii-reactive antibodies were detected in G3. In contrast, all G1 and G2 dogs developed 
signs of rickettsial infection, i.e., fever, lethargy, anorexia, ocular lesions, thrombocytopenia, anemia and detect-
able levels of Rickettsia DNA and R. rickettsii-reactive antibodies in their blood. Rickettsemia started 3-8 days after 
inoculation or tick infestation and lasted for 3-13 days. Our results indicate that a Brazilian strain of R. rickettsii 
is pathogenic for dogs, suggesting that canine clinical illness due to R. rickettsii has been unreported in Brazil and 
possibly in the other South American countries where BSF has been reported among humans. 
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The bacterium Rickettsia rickettsii is the etiological 
agent of an acute, severe disease called Rocky Mountain 
spotted fever (RMSF) in the United States or Brazilian 
spotted fever (BSF) in Brazil. In addition to these two 
countries, the disease has also been reported to affect 
humans in Mexico, Costa Rica, Panama, Colombia and 
Argentina (Paddock et al. 2008). Common clinical signs 
and symptoms are fever, nausea, vomiting, rash, myalgia, 
anorexia and headache. The case-fatality rate is 5-10% 
in the United States and 10-40% in Brazil (Galvão et al. 
2005, Angerami et al. 2006, Chapman et al. 2006).
Like humans, dogs are also susceptible to R. rick-
ettsii infection. However, despite the wide distribution 
of R. rickettsii in the Western Hemisphere, reports of 
R. rickettsii-induced illness in dogs have been restrict-
ed to the United States, where the following clinical 
abnormalities have been observed: fever, lethargy, an-
orexia, depression, cutaneous petechiae and echymoses, 
epistaxis, conjunctivitis, ocular discharge, lymph node 
enlargement, diarrhea, weight loss, dehydration and 
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central nervous system involvement (mostly paraparesis 
or tetraparesis, ataxia and vestibular syndrome). Hema-
tological abnormalities include anemia, thrombocytope-
nia and mild leucopenia at the onset of fever followed by 
leukocytosis (Keenan et al. 1977a, b, Breitschwerdt et al. 
1988, Comer 1991). Case-fatality rates in dogs have been 
reported to be 3% (Greene 1987), 7% (Greene et al. 1985) 
and 0% in a more recent study (Gasser et al. 2001).
Several serological studies among healthy Brazil-
ian dogs indicate that these animals were infected by R. 
rickettsii, as shown by high antibody titers to R. rick-
ettsii, at least four-fold higher than titers to other Rickett-
sia species known to occur in Brazil (Horta et al. 2004, 
2007, Pinter et al. 2008). However, nothing is known 
about the pathogenicity of South American strains of 
R. rickettsii for dogs. Since ecological differences and 
genetic polymorphisms between strains of R. rickettsii 
from the United States and South America have been 
reported (Eremeeva et al. 2003, Karpathy et al. 2007), 
it is not known how pathogenic South American strains 
of R. rickettsii are for dogs. For this purpose, the present 
study evaluated experimental infection of dogs with a 
Brazilian strain of R. rickettsii. 
MATERIALS AND METHODS
Eight six-month-old female dogs were used in the 
study, consisting of five mongrels and three beagles. 
Dogs were provided by a laboratory animal room, where 
they were reared with no contact with ticks and under 
strict sanitary control, being regularly treated with anti-
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worm medication (Pirantel, Febantel, Praziquantel; Ver-
mivet Plus®, Biovet, Brazil) and immunized with com-
mercial vaccines for enteroviruses, hepatitis, influenza 
and leptospirosis (Octa-Cino-Vacin®, Biovet, Brazil). 
During the two weeks before starting the experiment, 
the dogs were clinically healthy and their paired serum 
samples (14 days interval) were shown to contain no re-
active antibodies to either R. rickettsii (serologic reac-
tion performed as described below) or Ehrlichia canis 
[serologic reaction performed as described elsewhere 
(Aguiar et al. 2007)]. 
During the experiment, the dogs were maintained in 
individual runs in tick-free facilities, where water and 
commercial food were offered ad libitum. Dogs were as-
signed to three experimental groups. Group 1 (G1) was 
composed of three dogs that were each inoculated ip 
with ~ 3,000 Vero cells infected by R. rickettsii strain 
Taiaçu suspended in 1 mL of sucrose-phosphate-gluta-
mate buffer. The third cell passage was used to inoculate 
dogs. R. rickettsii strain Taiaçu was originally isolated 
from an Amblyomma aureolatum tick collected on a dog 
in Taiaçupeba District, Mogi das Cruzes Municipality, 
state of São Paulo (Pinter & Labruna 2006a). Group 2 
(G2) was composed of three dogs that were each infested 
by five pairs of R. rickettsii-infected A. aureolatum adult 
ticks derived from an experimental colony in our labora-
tory. Ticks of this colony were experimentally infected 
by R. rickettsii during the previous larval stage by feed-
ing on guinea pigs experimentally infected ip with the 
third Vero cell passage of strain Taiaçu. The R. rickettsii 
infection of the tick colony was confirmed by testing a 
random sample of 83 flat nymphs by a PCR protocol tar-
geting a fragment of the rickettsial gene gltA, as previ-
ously described (Pinter & Labruna 2006b). Since all 83 
nymphs were PCR positive, the colony was estimated to 
be 100% infected. In addition, these nymphs were fed 
on guinea pigs that developed severe febrile disease ex-
hibiting strong scrotal lesions and high lethality (Pinter 
& Labruna 2006b). For tick infestation, white cotton 
sleeves (15 cm × 15 cm) were glued to the back of each 
dog (Kamar heat detector adhesive, Kamar, Steamboat 
Springs, Co) and the adult ticks were released into the 
sleeve. The sleeves were opened daily and detached en-
gorged ticks were removed. Group 3 (G3) was composed 
of two dogs that were left uninfected as a control and 
each dog in this group was infested by five pairs of unin-
fected A. aureolatum adult ticks derived from a labora-
tory colony. These uninfected ticks were siblings of the 
experimentally-infected ticks described above. G1 and 
G2 each contained one beagle and two mongrel dogs, 
whereas G3 contained one beagle and one mongrel dog. 
Starting from the day of inoculation (G1) or infesta-
tion (G2 and G3) of the dogs (designated as day 0), each 
dog was examined daily for rectal temperature and clini-
cal abnormalities until 30 days following inoculation or 
infestation (DPI). Also, individual blood samples (0.2 mL 
per sample) were collected daily from 0-30 DPI for DNA 
extraction. Additional blood samples (2.5 mL per sam-
ple) were collected from each dog every two days from 
0-30 DPI, and divided into aliquots; one part solubilized 
in EDTA for hematology, one part without anticoagulant 
to separate serum for serology, and a third part used to 
inoculate guinea pigs ip (0.5 mL per guinea pig), with 
two guinea pigs being inoculated per dog at each time 
point. Rectal temperature was measured daily in each 
guinea pig until 21 DPI, but if a guinea pig presented 
at least two consecutive days of high fever (tempera-
ture > 40oC) within this period, it was euthanized and 
its spleen was collected and processed for DNA extrac-
tion and PCR for rickettsial DNA, as described below 
for canine blood. Every seven days from 31-90 DPI and 
every 14 days from 91-180 DPI, canine blood samples 
were collected without anticoagulant to separate serum 
for serology testing.
For hematology, blood cells were counted in an 
automatic counter (Horiba ABX Brasil, São Paulo, 
Brazil) to determine total number of red blood cells, 
white blood cells, and platelets, hemoglobin level and 
globular volume. 
DNA from canine blood (200 µL of whole blood from 
each sample) was extracted using the DNeasy Tissue Kit 
(Qiagen, Chatsworth, CA, USA) following the manufac-
turer’s protocols. All blood samples were individually 
processed by a real-time PCR assay with primers CS-5 
(5’ AGAGAAAATTATATCCAAATGTTGAT-3’) and 
CS-6 (5’ -AGGGTCTTCGTGCATTTCTT-3’), designed 
to amplify a 147 bp fragment of the citrate synthase gene 
(gltA) of Rickettsia spp. A fluorogenic probe [5’ 6-FAM 
d (CATTGTGCCATCCAGCCTACGGT) BHQ-1 3’] (In-
tegrated DNA Technologies, San Diego, CA, USA) posi-
tioned 76 bp downstream of the forward primer and 3 bp 
upstream of the reverse primer was used in the reactions 
(Labruna et al. 2004). Real-time PCRs were performed 
in a 7500 Real Time PCR Systems apparatus (Applied 
BioSystems, Foster City, CA, USA) with 25 µL per re-
action, which contained 2.5 µL of an individual blood 
DNA template, 2.5 µL of PCR buffer (10 X), 4 µL of de-
oxynucleotide triphosphates mixture (1.25 mM), 1.0  µL 
MgCl2 (50 mM), 0.1 µL of Platinum Taq DNA polymerase 
(5,000 U/mL) (Invitrogen, São Paulo, Brazil), 1 µL 
of each primer at 10 µM, 0.25 µL of the probe at 20 µM 
and bi-distilled water to a final volume of 25 µL. Real-
time PCR cycling conditions were as described by 
Labruna et al. (2004). This combination of primers and 
probe has shown a sensitivity down to 1 DNA copy of R. 
rickettsii (Labruna et al. 2004). For each reaction, five 
negative controls (2.5 µL of the same bi-distilled water 
mentioned above) and a positive control (300 ng of DNA 
of Rickettsia parkeri-infected Vero cells) were included.
Blood serum samples collected from days 0-180 DPI 
were tested by an indirect immunofluorescence assay 
(IFA) using a R. rickettsii strain Taiaçu crude antigen 
and a fluorescein isothiocyanate-labeled rabbit anti-dog 
IgG (Sigma, St Louis, USA), as previously described 
(Labruna et al. 2007). Canine sera were serially diluted 
in two-fold increments with PBS starting from 1:64 dilu-
tion. For each serum sample, the endpoint titer reacting 
with R. rickettsii was determined. In each slide, a serum 
previously shown to be non-reactive (negative control) 
and a known reactive serum (positive control) were 
tested at the 1:64 dilution. The geometric mean for each 
titer of the three groups was obtained as previously de-
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Fig. 1: selected clinical findings and rickettsemia duration for dogs of 
two experimental groups (G1 and G2) exposed to Rickettsia rickettsii 
infection. G1 consisted of three dogs (A, B and C) inoculated ip with 
R. rickettsii; G2 consisted of three dogs (D, E and F) infested with R. 
rickettsii-infected ticks.
scribed (Breitschwerdt et al. 1988). Additionally, canine 
sera from 24 and 180 DPI were tested by IFA against 
six Rickettsia species (R. rickettsii, R. parkeri, Rickett-
sia amblyommii, Rickettsia rhipicephali, Rickettsia felis, 
Rickettsia bellii) known to occur in Brazil (Labruna et 
al. 2007), in order to compare endpoint titers against ho-
mologous (R. rickettsii) and heterologous antigens (re-
maining Rickettsia species). 
The present study was previously approved by the 
Bioethical Committee in Animal Research of the Facul-
ty of Veterinary Medicine of the University of São Paulo 
(protocol 913/2006).
RESULTS
During the study, dogs from the control group (G3) 
showed neither clinical nor hematological abnormalities 
associated with rickettsial infection, nor were there any 
detectable Rickettsia DNA or reactive antibodies in their 
blood. In contrast, all dogs from both the G1 (inoculated 
via ip with R. rickettsii) and G2 (infected through infesta-
tion with R. rickettsii-infected ticks) developed signs of 
rickettsial infection, i.e., they showed clinical and hema-
tological abnormalities and detectable levels of Rickettsia 
DNA (rickettsemia) and reactive antibodies in their blood 
(Figs 1-3). Additionally, guinea pigs inoculated with G1 
and G2 canine blood from 2-14 DPI developed fever with-
in 48-96 h and, after being euthanized, their spleens were 
shown to contain rickettsial DNA. No guinea pig inocu-
lated with blood from G3 dogs developed fever. 
Clinical indications among dogs from both groups G1 
and G2 were similar, except for one G2 dog, which pre-
sented ocular lesions characterized by bilateral ocular dis-
charge, scleral congestion and conjunctival edema. Dogs 
from the G1 presented rickettsemia, anorexia, fever (rectal 
temperature > 39.5oC) and lethargy earlier than G2 dogs 
(Fig. 1). In each group, clinical signs generally occurred 
within the febrile period. Thus, rickettsemia, defined as 
the presence of rickettsial DNA detected in dog blood 
by our real-time PCR assay, was first detected at 2 DPI 
in G1 dogs and at 6 DPI in G2 dogs. The duration of rick-
ettsemia in infected dogs was limited, ranging from three 
days (dogs C, E and F) to 13 days (dog B) (Fig. 1). 
Regarding hematologic changes, hemoglobin con-
centration, package cell volume and platelet counts de-
creased below the reference range for dogs during the 
febrile period in both G1 and G2, with values remaining 
lower for up to six days after the febrile period in G2 
dogs (Fig. 2). No marked change in erythrocyte or leuko-
cyte counts was observed. Clinical and hematologic ab-
normalities resolved in G1 and G2 dogs without seque-
lae. No dog presented hemorrhagic (including cutaneous 
or mucous), locomotor or neurological signs during the 
study, during which no antibiotic was administrated.
During the study, G3 dogs remained seronegative to 
R. rickettsii at the 1:64 serum dilution. The antibody re-
sponse to R. rickettsii was first documented on DPI 4 for 
G1 dogs and DPI 8 for G2 dogs (Fig. 3). Mean peak titers 
were reached by DPI 24 or 44 for G1 or G2 dogs, re-
spectively. Mean serum titers to R. rickettsii essentially 
remained stable through 114 DPI for G2 and then de-
creased slowly through 180 DPI. Despite the higher and 
earlier peak titers observed in G1 dogs, their mean titer 
decreased slowly in a pattern similar to that of G2 dogs. 
For G1 dogs, individual sera reached peak titers of 
32,768-65,536 to R. rickettsii, and then decreased slowly 
3-5 dilutions through 180 DPI, when titers ranged from 
2,048-4,096. For G2 dogs, individual sera reached peak 
titers of 32,768 for all three dogs, and then decreased 
slowly 2-4 dilutions through 180 DPI, when titers ranged 
from 2,048-8,192.
Canine sera from 24 and 180 DPI tested against six 
rickettsial antigens all showed higher titers to R. rick-
ettsii than to R. parkeri, R. amblyommii, R. rhipicephali, 
R. felis and R. bellii, or the same titer for both R. rick-
ettsii and R. parkeri in one dog at 180 DPI (Table). In 
four dogs at 24 DPI and two dogs at 180 DPI titers to R. 
rickettsii were at least four-fold higher to R. rickettsii 
than to the remaining Rickettsia species.
DISCUSSION
In the present study, dogs became ill after exposure 
to strain Taiaçu of R. rickettsii through both ip inocula-
tion of the agent or via the parasitism of R. rickettsii-
infected ticks. This latter exposure method mimicked 
natural conditions in some areas of the state of São 
Paulo, where dogs are exposed to R. rickettsii-infected 
A. aureolatum ticks, a known vector of the disease in hu-
mans (Pinter et al. 2004, Pinter & Labruna 2006a). Thus, 
our results indicate that a Brazilian strain of R. rickettsii 
is pathogenic for dogs, despite the fact there has been no 
report of clinical illness caused by R. rickettsii among 
Brazilian dogs, including all areas where BSF has been 
reported in humans. 
Experimental studies on canine RMSF have shown 
that the severity of the induced illness is related to the in-
fectious dose of R. rickettsii (Keenan et al. 1977a, b). In 
those studies, dogs were inoculated intravenously with 
gradually increasing doses of yolk sac suspensions of R. 
rickettsii, which resulted in fatalities among dogs receiv-
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ing higher doses (Keenan et al. 1977a, b). In the present 
study, G1 dogs were inoculated ip with a very high dose 
of tissue-cultured R. rickettsii (≈ 3,000 infected Vero 
cells), whereas G2 dogs were infected via tick parasit-
Fig. 2: mean values of rectal temperature and hematologic values for dogs of three experimental groups (G1, G2 and G3) evaluated during 30 
days after exposure to Rickettsia rickettsii: G1 (□—□) consisted of three dogs inoculated ip with R. rickettsii; G2 (▲—▲) consisted of three dogs 
infested with R. rickettsii-infected ticks; G3 (x—x) consisted of two dogs infested with uninfected ticks, being the uninfected control group. 
Shaded areas represent laboratory reference range in the Veterinary Hospital of the University of São Paulo.
Fig. 3: serologic response of dogs of two experimental groups (G1 and 
G2) to Rickettsia rickettsii antigen by the indirect immunofluores-
cence assay (IFA). G1 (□—□) consisted of three dogs inoculated ip 
with R. rickettsii; G2 (▲—▲) consisted of three dogs infested with R. 
rickettsii-infected ticks.
ism (at most 10 infected adult ticks per dog). Since the 
onset of fever and rickettsemia occurred at least three 
days later in G2 dogs in comparison to G1 dogs (Fig. 1), 
one might suppose that these latter dogs were exposed 
to a higher R. rickettsii-infective dose, which should 
have induced a more severe disease. However, our re-
sults showed that G2 dogs (infected via ticks) devel-
oped a slightly more severe illness, with higher rectal 
temperatures and lower platelet, packed cell volume and 
hemoglobin values, all of which lasted days longer than 
in G1 dogs (Fig. 2). In addition, the only dog presenting 
ocular lesions belonged to G2. The causes for such dif-
ferences could be related to mode of acquisition of the 
R. rickettsii infection. While G1 dogs received a single, 
but high infectious dose at DPI 0, G2 dogs might have 
received lower infectious doses over several consecutive 
days during tick engorgement. In addition, disease se-
verity in G2 dogs could be affected by the tick-passage 
of strain Taiaçu since G1 dogs were inoculated directly 
with the third in vitro passage.
Dogs of the present study presented rickettsemia (as 
determined by detectable rickettsial DNA by real-time 
PCR and by inoculation of guinea-pigs with canine 
blood) lasting from 3-13 days (mean = 8.3 days for G1, 
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4.3 days for G2). These periods are similar to those re-
ported by Norment and Burgdorfer (1984), who found 
rickettsemia (determined by meadow vole inoculation) 
lasting from 3-7 days, with mean rickettsemia periods 
lasting for 4.3 or 6.3 days when dogs were infected by 
R. rickettsii via ip injection with yolk sac suspension or 
via parasitism of infected Dermacentor andersoni ticks, 
respectively. Since the real-time PCR assay employed in 
the present study has been shown to detect as few as one 
copy of the R. rickettsii genome (Labruna et al. 2004), 
this technique seems to be useful for the determination 
of rickettsemia in animal blood. 
Both G1 and G2 dogs developed high R. rickettsii-
antibody titers, which remained high (≥ 2,048) at 180 
DPI. Although Keenan et al. (1977b) detected R. rick-
ettsii-reactive antibodies in dogs 12 months after ex-
perimentally induced infection, it is not known how 
long antibodies persist in dogs (Magnarelli et al. 1982). 
Therefore, seropositivity may not necessarily indicate a 
very recent infection. On the other hand, long periods 
of seroreactivity highlight the important role of dogs as 
sentinels for surveillance of RMSF or BSF (Sexton et al. 
1976, Lemos et al. 1996, Paddock et al. 2002, Sangioni 
et al. 2005) since a seroreactive dog indicates circulation 
of spotted fever group rickettsia in a given area, at least 
within the previous 6-12 months. 
Serological tests at 24 DPI (around peak titers) and 
180 DPI (end of study) showed higher endpoint titers to 
R. rickettsii (homologous reaction) than to the other five 
Rickettsia species (heterologous reaction) known to occur 
in Brazil, except for one dog at 180 DPI that showed the 
same titer for both R. rickettsii and R. parkeri. Previous 
canine serology surveys in Brazil used the criteria that 
when a serum displayed an endpoint titer for a given Rick-
ettsia species at least four-fold higher than that observed 
for any other Ricketttsia species, that serum would be 
considered homologous to the first Rickettsia species or 
to a very closely related genotype (Horta et al. 2004, 2007, 
Labruna et al. 2007, Pinter et al. 2008). This assumption 
is supported by the present study since no dog showed a 
higher titer to heterologous antigens, and six sera showed 
titers to R. rickettsii at least four-fold higher than the titers 
to the remaining Rickettsia species (Table).
The results of the present study strongly suggest that 
canine clinical illness due to R. rickettsii has gone unre-
ported in Brazil. It is possible that some of these cases 
have been misidentified as canine monocytic ehrlichio-
sis (CME), a highly prevalent tick-borne disease in Bra-
zil that is caused by E. canis (Aguiar et al. 2007), which 
induces clinical and hematologic symptoms in dogs very 
similar to those caused by R. rickettsii (Greene et al. 
1985, Grindem et al. 1999). 
Finally, Brazilian veterinary clinicians should in-
clude R. rickettsii infection in a differential diagnosis of 
CME and other acute nonspecific febrile illness of dogs, 
especially because R. rickettsii is highly pathogenic for 
humans. It is likely that the occurrence of illness due to 
R. rickettsii in a pet dog means that there is a risk of con-
tracting the disease by humans living in the same resi-
dence (in close contact with ticks). For instance, there 
have been several reports of concurrent RMSF in dogs 
and their owners (Paddock et al. 2002, Elchos & Goddard 
2003). Therefore, proper diagnosis of BSF in dogs might 
alert owners to take measures to prevent the occurrence 
or even the lethality of the disease in humans. Due to the 
persistence of R. rickettsii-reactive antibodies in infected 
dogs for at least 6-12 months, dog-directed serologic sur-
veys may alert owners that the pathogen is endemic to 
their immediate environment and also provide doctors 
with a presumptive diagnosis for dog owners presenting 
with unexplained febrile illness (Paddock et al. 2002). 
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TABLE
Endpoint antibody titers by indirect immunofluorescence assay (IFA) to six Rickettsia species in dogs from Group 1 (G1) (A, B 
and C) and Group 2 (G2) (D, E and F) at 24 and 180 days post inoculation or infestation (DAI). G1 dogs were inoculated ip with 
R. rickettsii and G2 dogs were infested with R. rickettsii-infected ticks
                                                                  IFA endpoint titer to the following rickettsial antigens 
Dog (DAI) R. rickettsii R. parkeri R. amblyommii R. rhipicephali R. felis R. bellii
A (24) 32768 4096 4096 1024 512 512
B (24) 16384 8192 4096 1024 1024 2048
C (24) 65536 32768 4096 1024 1024 1024
D (24) 16384 4096 2048 1024 256 512
E (24) 8192 2048 2048 2048 256 512
F (24) 8192 2048 1024 512 256 512
A (180) 4096 2048 512 512 < 64 < 64
B (180) 4096 4096 2048 2048 128 128
C (180) 2048 1024 1024 512 256 512
D (180) 2048 512 512 128 128 128
E (180) 4096 1024 512 512 <64 64
F (180) 8192 4096 256 64 64 64
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